Literature DB >> 6257108

Pneumonia: an eleven-year study in a pediatric practice.

T F Murphy, F W Henderson, W A Clyde, A M Collier, F W Denny.   

Abstract

Data from an 11-year study of acute lower respiratory tract illness were analyzed to provide added insight into the causes and patterns of occurrence of pneumonia in an outpatient pediatric population. Over 80% of all episodes of pneumonia occurred in children less than seven years of age; the peak attack rate was observed in 2-4-year-old children. A virus or Mycoplasma pneumoniae was isolated from 24% of children with pneumonia; 57% of all episodes occurred during outbreaks for which a viral or mycoplasmal cause could usually be identified. Respiratory syncytial virus (RSV), parainfluenza viruses types 1 and 3, adenoviruses, influenza A viruses and M. pneumoniae accounted for 86% of all isolates. Attack rates of pneumonia in preschool children were highest during periods of RSV and influenza A virus prevalence; M. pneumoniae was the most frequent isolate from school aged children. The data contained in this report augment the understanding of the causes of pneumonia in children and provide a data base for scientists interested in the prevention of lower respiratory tract illness in children.

Entities:  

Mesh:

Year:  1981        PMID: 6257108     DOI: 10.1093/oxfordjournals.aje.a113061

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  42 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland.

Authors:  M Patrzałek; P Albrecht; M Sobczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-01       Impact factor: 3.267

Review 3.  What imaging should we perform for the diagnosis and management of pulmonary infections?

Authors:  Sjirk J Westra; Garry Choy
Journal:  Pediatr Radiol       Date:  2009-04

4.  Indirect population impact of universal PCV7 vaccination of children in a 2 + 1 schedule on the incidence of pneumonia morbidity in Kielce, Poland.

Authors:  M Patrzalek; P Gorynski; P Albrecht
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-16       Impact factor: 3.267

5.  [Erythromycin versus amoxicillin for the treatment of pneumonia in children (author's transl)].

Authors:  H Ruhrmann; H Blenk
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  Effects of social and family factors on viral respiratory infection and illness in the first year of life.

Authors:  G Gardner; A L Frank; L H Taber
Journal:  J Epidemiol Community Health       Date:  1984-03       Impact factor: 3.710

Review 7.  Community-acquired pneumonia.

Authors:  Mark Loeb
Journal:  BMJ Clin Evid       Date:  2008-07-17

8.  The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand.

Authors:  Alicia M Fry; Malinee Chittaganpitch; Henry C Baggett; Teresa C T Peret; Ryan K Dare; Pongpun Sawatwong; Somsak Thamthitiwat; Peera Areerat; Wichai Sanasuttipun; Julie Fischer; Susan A Maloney; Dean D Erdman; Sonja J Olsen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  Improving outcomes for ill and injured children in emergency departments: protocol for a program in pediatric emergency medicine and knowledge translation science.

Authors:  Shannon Scott; Lisa Hartling; Jeremy Grimshaw; David Johnson; Martin Osmond; Amy Plint; Rollin Brant; Jamie C Brehaut; Ian D Graham; Gillian Currie; Nicola Shaw; Maala Bhatt; Tim Lynch; Liza Bialy; Terry Klassen
Journal:  Implement Sci       Date:  2009-09-22       Impact factor: 7.327

10.  Community-acquired pneumonia in children.

Authors:  H Dele Davies
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.